Venlo, the Netherlands, May 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables ...
QIAGEN N.V. QGEN recently announced that its consumables kits have been used to process more than 3 billion biological samples. This milestone underlines QIAGEN’s leading position in sample ...
QIAGEN N.V. and NanoCellect Biomedical, Inc., a leader in cell analysis and sorting technology, announced a scientific collaboration to improve the cell sample prep upstream of QIAGEN's QIAseq UPX 3 ...
QIAGEN N.V. QGEN recently announced that it is working with genetic laboratories to ramp up COVID-19 testing capacity with its artus SARS-CoV-2 Prep&Amp UM Kit. Notably, the kit utilizes liquid-based ...
This customized kit will incorporate a specific version of QIAGEN's well-established QIAamp (R) technology to purify DNA from specimens stored in liquid cytology media. QIAGEN's proprietary nucleic ...
Qiagen has announced the launch of AllPrep RNA/Protein Kit, designed to purify total RNA and native protein simultaneously from the same sample of cultured cells. The purified RNA and protein provide ...
Venlo, the Netherlands, May 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QIAseq Multimodal DNA/RNA Lib Kit. The new kit enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results